SAE1.F SHOP APOTH. UNSP.ADR/010
- Market cap
- EUR 1.29B
- P/E
- -
- P/B
- 2.86x
- ROE
- -1.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is SAE1.F undervalued?
Graham numberThe Graham number of SHOP APOTH. UNSP.ADR/010 cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
SHOP APOTH. UNSP.ADR/010 fundamental analysis
No fundamental analysis for SHOP APOTH. UNSP.ADR/010 yet.
SHOP APOTH. UNSP.ADR/010 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About SHOP APOTH. UNSP.ADR/010
Redcare Pharmacy NV operates the online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It offers prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. Redcare Pharmacy NV was founded in 2001 and is based in Sevenum, the Netherlands.
Full company profileSHOP APOTH. UNSP.ADR/010 financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
SHOP APOTH. UNSP.ADR/010 annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 1.06B | 1.20B | 1.80B | 2.37B | 2.94B | 3.40B |
| Gross Profit | 267M | 332M | 440M | 546M | 663M | 735M |
| Operating Income | -65.9M | -69.3M | -17.3M | -39.0M | -29.8M | 27.3M |
| EBITDA | - | -36.1M | 50.9M | 28.1M | 48.1M | 96.0M |
| Net Income | -74.2M | -77.6M | -12.0M | -45.5M | -37.7M | -6.67M |
| EPS | -4.10 | -4.27 | -0.61 | -2.26 | -1.87 | -0.33 |
| Balance Sheet | ||||||
| Total Assets | 783M | 729M | 1.02B | 1.00B | 1.21B | 1.15B |
| Total Liabilities | 368M | 375M | 470M | 493M | 735M | 677M |
| Shareholders' Equity | 415M | 355M | 522M | 484M | 459M | 458M |
| Cash & Short-term Investments | 247M | 66.8M | 83.8M | 96.6M | 92.1M | 89.6M |
| Cash Flow | ||||||
| Operating Cash Flow | 11.6M | -29.1M | 61.5M | 22.1M | 31.0M | 90.0M |
| Capital Expenditure | 43.2M | 53.5M | 38.2M | 42.1M | 119M | 75.7M |
| Free Cash Flow | -31.5M | -82.6M | 23.2M | -20.0M | -87.6M | 14.3M |
| Ratios | ||||||
| ROE | -17.9% | -21.9% | -2.3% | -9.4% | -8.2% | -1.5% |
| ROA | -9.5% | -10.6% | -1.2% | -4.5% | -3.1% | -0.6% |
| Net Profit Margin | -7.0% | -6.4% | -0.7% | -1.9% | -1.3% | -0.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
SHOP APOTH. UNSP.ADR/010 dividends
SHOP APOTH. UNSP.ADR/010 has not paid dividends in the last 5 fiscal years.
Who owns SHOP APOTH. UNSP.ADR/010
Ownership data of SHOP APOTH. UNSP.ADR/010 is not available yet.
SHOP APOTH. UNSP.ADR/010 company profile
- Company name
- SHOP APOTH. UNSP.ADR/010
- Ticker
- SAE1.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Consumer Staples Distribution & Retail
- Employees
- 2,163
- Fiscal year end
- December
- Address
- Erik de Rodeweg 11/13, Sevenum, Netherlands, 5975 WD
- Phone
- 800 200 800 300
- Website
- redcare-pharmacy.com
About SHOP APOTH. UNSP.ADR/010
Redcare Pharmacy NV operates the online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It offers prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. Redcare Pharmacy NV was founded in 2001 and is based in Sevenum, the Netherlands.
SHOP APOTH. UNSP.ADR/010 management
10- Mr. Michael KöhlerCo-Founder & Chairperson of Supervisory Board · born 1962
- Mr. Stephan WeberCo-Founder & Member of Supervisory Board · born 1979
- Mr. Hendrik KrampeCFO & Member of Management Board · born 1971
- Ms. Theresa HollerCOO & Member of the Managing Board · born 1973
- Mr. Lode FastréChief Information Officer & Member of Management Board
- Mr. Schmid von LinstowCEO & Member of the Managing Board · born 1971
- Ms. Monica AmbrosiAssociate Director of Investor Relations
- Mr. Patrick SchneiderChief Sales Officer
- Ms. Beate KroschDirector of Human Resources
- Mr. Nana LohmannsChief E-Health Officer